We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.73B
AUM Growth
-$641M
Cap. Flow
-$442M
Cap. Flow %
-11.83%
Top 10 Hldgs %
5.17%
Holding
1,489
New
168
Increased
277
Reduced
362
Closed
84

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$18.8M
2
WAT icon
Waters Corp
WAT
+$15.6M
3
CMI icon
Cummins
CMI
+$15.3M
4
CI icon
Cigna
CI
+$15.1M
5
AMP icon
Ameriprise Financial
AMP
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 27.38%
2 Energy 11.53%
3 Industrials 10.56%
4 Consumer Discretionary 10.28%
5 Technology 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SURF
1151
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$190K 0.01%
182,500
+82,500
+83% +$132K
TARA icon
1152
Protara Therapeutics
TARA
$232M
$189K 0.01%
64,000
HOWL icon
1153
Werewolf Therapeutics
HOWL
$19.3M
$188K 0.01%
41,711
+5,500
+15% +$29.9K
SCWX
1154
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$187K 0.01%
23,180
VIRC icon
1155
Virco
VIRC
$96.3M
$185K 0.01%
43,400
KSCP icon
1156
Knightscope
KSCP
$31.6M
$182K ﹤0.01%
1,500
CRIS icon
1157
Curis
CRIS
$7.83M
$180K ﹤0.01%
642
+600
+1,429% +$242K
ELUT icon
1158
Elutia
ELUT
$37.6M
$179K ﹤0.01%
24,900
WYY icon
1159
WidePoint Corp
WYY
$114M
$179K ﹤0.01%
84,228
-25,000
-23% -$61.7K
LAB icon
1160
Standard BioTools
LAB
$314M
$178K ﹤0.01%
+162,000
New +$245K
CLYM
1161
Climb Bio
CLYM
$804M
$178K ﹤0.01%
55,223
+34,800
+170% +$111K
IRNT
1162
DELISTED
IronNet, Inc.
IRNT
$178K ﹤0.01%
+258,000
New +$524K
MCHX icon
1163
Marchex
MCHX
$79.7M
$176K ﹤0.01%
104,600
GHM icon
1164
Graham Corp
GHM
$1.31B
$173K ﹤0.01%
19,700
-24,100
-55% -$201K
SCPX
1165
DELISTED
Scorpius Holdings, Inc.
SCPX
$173K ﹤0.01%
25
VNRX icon
1166
VolitionRx Ltd
VNRX
$9.34M
$171K ﹤0.01%
6,305
-5,750
-48% -$217K
BCAB icon
1167
BioAtla
BCAB
$5.74M
$169K ﹤0.01%
+440
New +$144K
BOLT icon
1168
Bolt Biotherapeutics
BOLT
$7.78M
$168K ﹤0.01%
5,660
+2,385
+73% +$98.7K
CNVS icon
1169
Cineverse
CNVS
$65.6M
$168K ﹤0.01%
21,225
AQST icon
1170
Aquestive Therapeutics
AQST
$494M
$167K ﹤0.01%
142,956
-61,400
-30% -$69.4K
FSI icon
1171
Flexible Solutions
FSI
$64.1M
$167K ﹤0.01%
101,007
HCWB icon
1172
HCW Biologics
HCWB
$5.45M
$166K ﹤0.01%
303
ICD
1173
DELISTED
Independence Contract Drilling, Inc.
ICD
$165K ﹤0.01%
55,000
LTRPA
1174
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$164K ﹤0.01%
150,000
+100,000
+200% +$105K
NNVC icon
1175
NanoViricides
NNVC
$36.2M
$163K ﹤0.01%
94,039

Similar funds

Bridgeway Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bridgeway Capital Management held 1,489 positions worth $3.73B, down 15% from $4.38B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Bridgeway Capital Management withdrew a net $442M in Q3 2022, closing 84 positions and reducing 362 holdings. Its most notable exit was L3Harris, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Cleveland-Cliffs worth $11M.

  • Bridgeway Capital Management's largest Q3 2022 buy was Cleveland-Cliffs: 819,000 shares worth $11M.
  • Bridgeway Capital Management added most to Meta Platforms (Facebook) in Q3 2022, an estimated $13.9M increase.
  • Bridgeway Capital Management's biggest Q3 2022 reduction was Waters Corp, cutting an estimated $15.6M.
  • Bridgeway Capital Management fully exited L3Harris in Q3 2022, selling an estimated $18.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.2% of its $3.73B portfolio in Q3 2022.
  • Bridgeway Capital Management opened 168 new positions and closed 84 in Q3 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $3.73B.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.